31 Jan, 2020 THC Global Quarterly Update & Appendix 4C 31 January 2020 21 Jan, 2020 TGA GMP Manufacturing Licence Granted for Southport Facility 20 Jan, 2020 THC – Product Supply Agreement Signed with MGC Pharma 4 Dec, 2019 First Medicinal Cannabis Processed at Southport Facility 19 Nov, 2019 THC Global Shareholder Update 19 November 2019 11 Nov, 2019 Manufacturing Permit Received for Southport Facility 30 Oct, 2019 THC Global Quarterly Update & Appendix 4C 30 September 2019 21 Oct, 2019 THC Global Builds New Zealand CBD Presence 17 Oct, 2019 THC Global Two Facilities Receive S4 and S8 Narcotics Licences 24 Sep, 2019 THC Global Group Limited Corporate Presentation September 2019 23 Sep, 2019 THC Global Limited (ASX:THC) Change of Address 5 Sep, 2019 THC Global Group secures 24.6ha cannabis cultivation site 2 Sep, 2019 2019 THC Half Yearly Report and Accounts 29 Aug, 2019 THC Global Group Limited Southport Facility Opened by Federal Minister for Health 31 Jul, 2019 THC Global THC Global Quarterly Update & Appendix 4C 31 July 2019 9 Jul, 2019 Eve Investments – THC Global Agreement Update 9 Jul, 2019 THC Global Southport Manufacturing Facility Licenced 13 Jun, 2019 THC Global Granted Cannabis Manufacture Licence 28 May, 2019 Results of Annual General Meeting 28 May, 2019 Chairman’s Address 15 May, 2019 THC Global Expands Cultivation & Export Licence Granted 6 May, 2019 THC Global SPP Completed & Appendix 3B 1 May, 2019 THC Global Quarterly Update & Appendix 4C 30 April 2019 23 Apr, 2019 Notice of Annual General Meeting 28 May 2019 18 Apr, 2019 THC Global April 2019 Share Purchase Plan Update 17 Apr, 2019 THC Global Hydroponic Equipment Operations Update 10 Apr, 2019 THC Global Group Share April 2019 Purchase Plan – Offer Documents 5 Apr, 2019 THC Global Launches Share Purchase Plan 5 Apr, 2019 THC Global Continues Global Expansion – Asia Strategy 29 Mar, 2019 THC Global Group Limited Consolidated Financial Report 31 December 2018 26 Mar, 2019 Canadian Cannabis Production Site Acquisition Completed 28 Feb, 2019 THC Global Group Limited Appendix 4E 2018 Preliminary Financial Report 1 Feb, 2019 THC Global Corporate Update – January 2019 and Appendix 4C 15 Jan, 2019 Appointment of Group Chief Financial Officer 21 Dec, 2018 Australian Cannabis Permits Granted to THC Global 28 Nov, 2018 THC Global Expands into New Zealand Medicinal Cannabis Market 28 Nov, 2018 Issue of Securities Following Shareholder Approval & Apps 3Y 22 Nov, 2018 THC ASX Announcement 22 November 2018 change of name to THC Global Group Limited 22 Nov, 2018 THC ASX Announcement Canadian Cannabis Growing Facility Binding Agreement Signed 15 Nov, 2018 Results of EGM 2 Nov, 2018 First Australian Patients Prescribed Endoca CBD Products 31 Oct, 2018 THC Quarterly Update 31 October 2018 16 Oct, 2018 THC Positioned for Canadian Recreational Cannabis 12 Oct, 2018 THC Limited Investor Update 12 Oct, 2018 Notice of Extraordinary Meeting/Proxy Form 30 Aug, 2018 2018 THC Half Yearly Reports and Accounts 30 Aug, 2018 Change of Company Secretary and Registered Company Offices 31 Jul, 2018 Australian Patients Can Now Access Endoca Medicinal Cannabis 30 Jul, 2018 Canadian Hydroponics Division and Restatement of Objectives 11 Jul, 2018 Acquisition Delivers $16m to Balance Sheet & MC Strategy 11 Jul, 2018 THC Appoints CEO & Experienced Medicinal Cannabis Team 9 Jul, 2018 THC Executes Initial Cooperation Agreement With Endoca 6 Jul, 2018 THC North American Update 28 Jun, 2018 Cannabis Strains Exchange with Canadian Licensed Producer 26 Jun, 2018 Appointment of Product & Regulatory Affairs Manager 25 Jun, 2018 Inaugural Shipment of Medicinal Cannabis Received from Endoca 21 Jun, 2018 Final Hurdle Cleared For Legalisation Of Recreational Cannabis In Canada 8 Jun, 2018 THC Rec Ready – Canada Passes Recreational Cannabis Law 7 May, 2018 THC Australian Operations Update 4 May, 2018 Australian Canadian Clinic Rollout Halted 3 May, 2018 THC Secures Additional Site for Medicinal Cannabis Growth and Supply Agreements 26 Apr, 2018 THC Acquires Australian Biomanufacturing Facility 26 Apr, 2018 Appendix 4C – March Quarterly 12 Apr, 2018 Shareholder Update: Executive Team Appointed 23 Mar, 2018 AGM Chairman’s Address to Shareholders 23 Mar, 2018 Results of Annual General Meeting 23 Mar, 2018 2018 AGM Presentation 16 Mar, 2018 2018 AGM Update and Revised Proxy Forms 15 Mar, 2018 Results of EGM 14 Mar, 2018 Resignation of Chief Executive Officer 13 Mar, 2018 Resignation of Chief Commercial Officer 2 Mar, 2018 2017 Annual Report 2 Mar, 2018 THC Welcomes Simplified Access to Medicinal Cannabis in NSW 2 Mar, 2018 Canada Update 28 Feb, 2018 Granting of Endoca Import Permits and Clinical Trial Support 28 Feb, 2018 Appendix 4E – Preliminary Final Report 15 Feb, 2018 Queensland Growing Facility Update 13 Feb, 2018 Notice of Inaugural Annual General Meeting and Proxy Forms 8 Feb, 2018 ASIC Consent to Extension of Time to Hold Inaugural AGM 8 Feb, 2018 Company Response to EGM Notice Issued by Alan Beasley 7 Feb, 2018 Clinic Rollout Update 6 Feb, 2018 Chairman’s Letter and Notice of Meeting from A Beasley 31 Jan, 2018 Quarterly Company Update 24 Jan, 2018 Canadian Business Update 19 Jan, 2018 SPP Update 16 Jan, 2018 Australian Business Update 12 Jan, 2018 Appointment of new director 12 Jan, 2018 Meetings of Shareholders 5 Jan, 2018 THC To Import First Medicinal Cannabis Products In Early 2018 & Welcomes Fed Gov Export Approval 21 Dec, 2017 Exclusive Distribution Agreement with Nanolux Technology 14 Dec, 2017 Successful Share Placement and SPP 7 Dec, 2017 THC Announces Licensing Agreement with National Access Canada – Leading Clinic Chain in Canada 29 Nov, 2017 THC Shareholder Update 21 Nov, 2017 THC Appoints Chief Commercial Officer 20 Nov, 2017 THC Enters Partnership With Israeli Medicinal Cannabis Pioneer, BOL Pharma 15 Nov, 2017 Distribution Agreement Signed with Major European Supplier 13 Nov, 2017 THC Investor Presentation – November 2017 30 Oct, 2017 Medicinal Cannabis Licence Recieved 27 Oct, 2017 September Quarterly Activities Report 19 Oct, 2017 Group CEO Appointment, New Chairman and Board Changes 5 Sep, 2017 Executive Team – International Business and Prospects Report 1 Sep, 2017 Partnership for National Roll Out of Medicinal Cannabis Facilitated Prescribing and Dispensing 31 Aug, 2017 2017 Half Yearly Results and Accounts 16 Aug, 2017 Appointment of Company Secretary and Chief Financial Officer 2 Aug, 2017 Quarterly Business Review 13 Jul, 2017 Medicinal Cannabis Licences – Update 11 Jul, 2017 Medicinal Cannabis Research Licence Granted 20 Jun, 2017 Shareholder Update 6 Jun, 2017 Updated Investor Presentation 24 May, 2017 Strategic Alliance Formed with US-Based Pharmaceutical Company 16 May, 2017 Proactive Investor Presentation 11 May, 2017 Medicinal Cannabis CEO to Present at Investor Forum 5 May, 2017 1st Qtr Revenue up 22% and US Expansion 4 May, 2017 THC debuts on the ASX 3 May, 2017 Admission & Commencement of Official Quotation 5 Apr, 2017 Appointment of Executive Director 9 Mar, 2017 THC prospectus for Initial Public Offering March 2017
